Mindfulness-Based Therapy for Insomnia with Cognitive-Behavioral Symptom Coping Skills for Blood Cancers

Study Summary

This trial is studying a new approach to treating insomnia for patients with hematologic cancer who frequently report significant difficulties with sleep. The new approach is called Mindfulness-Based Therapy for Insomnia (MBTI) and it is a group-based intervention that combines sleep restriction and stimulus control with mindfulness principles and exercises to reduce worry and promote positive responses to insomnia. The study will be conducted in two phases. In Phase I, the study team will use focus groups with hematologic cancer patients and hematology-oncology providers to guide development along with user testing with hematologic cancer patients reporting insomnia and daytime symptoms of fatigue, pain,

Treatment Effectiveness

Study Objectives

Trial Safety

Trial Design

Trial Logistics

Eligibility Criteria